What does Genenta Science S.p.A. do?

Genenta Science S.p.A. is a public company in the Biological Products, (No Diagnostic Substances) industry, incorporated in L6. It is registered with the SEC under CIK 0001838716 and trades on NASDAQ under the ticker GNTA.

How many SEC filings has Genenta Science S.p.A. made?

Genenta Science S.p.A. has filed 91 documents with the SEC since 2021. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Genenta Science S.p.A.

GNTA NASDAQ CIK: 0001838716 Biological Products, (No Diagnostic Substances) Inc. in L6

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 91 filings →

Form	Description	Date
6-K	6-K	Mar 27, 2026
3	3	Mar 25, 2026
6-K	6-K	Mar 24, 2026
3	3	Mar 18, 2026
3	3	Mar 18, 2026
3	3	Mar 18, 2026
3	3	Mar 18, 2026
3	3	Mar 18, 2026
424B5	424B5	Jan 27, 2026
SCHEDULE 13G/A	—	Jan 27, 2026

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Genenta Science S.p.A.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Financial data not yet loaded.

Details

CIK: 0001838716
Ticker: GNTA
Exchange: NASDAQ
Incorporated: L6
First Filing: 2021
Total Filings: 91

Biological Products, (No Diagnostic Substances) rankings →